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The rate of formation of diferric-transferrin has been studied using various combinations of Fe(II), Tf, 
Cp and h serum. When the reactants were added in a correct physiological sequence, ceruloplasmin and 
diluted human serum showed the fastest rate of saturation of transferrin. 
Transfer&z, diferric Human serum Saturation rate 
Reaction sequence Physiological conditions 
1. 1NTRODUCTION 2. MATERIALS AND METHODS 
Ceruioplasmin (Cp, ferroxidase; iron (II):02 ox- 
idoreductase, EC 1.16.3.1) is the blue copper pro- 
tein of vertebrate plasma [l]. The multifunctional 
nature of this protein is now well documented [2]. 
Cp has been shown in vivo to be a direct molecular 
link between iron and copper metabolism [3,4J. It 
has been proposed that the ferroxidase activity of 
Cp promoted the rate of formation of 
Fe(III)z-transferrin (Tf) in serum [3]. 
In [5,6] it has been attempted to discount the 
role of Cp in several in vitro experiments utilizing 
Fe(III)z-Tf formation. Authors in [7] have 
described a reaction leading to the formation of 
Fe(III)z-Tf using Fe(I1) ions as the source of iron; 
ambient oxygen along with HCOp (5.0 or 10 mM) 
was shown to be a rate enhancement factor. 
However, they did not use Cp. We wish to provide 
evidence that these in vitro experiments do not pro- 
vide data appropriate for conditions which ap- 
proach the in vivo fate of Fe(I1) as it enters the 
plasma from the liver or other tissues. Under con- 
ditions approaching physiological Cp has a mark- 
ed acceleratory effect on the rate of formation of 
Fe(III)Z-Tf. We will use the set of reactions in 
table 1 to illustrate and identify Fe(I1) oxidation 
reactions under consideration. 
Cp was isolated from human plasma by a 
modified method [S]. The absorbance ratio 
%lo/Azse for human Cp was 0.045. Human Tf 
was obtained from Behringwerke (maximum iron 
content 20 pg/g). All solutions were prepared in 
chelexed water and further purified by using 
Cheiex-100 resin to remove trace metal contamina- 
tion. Tf saturation was determined at 37°C as in 
[9]. To the buffer, reagents were mixed in the order 
represented by the sequence of reactants in table 1 
at l-min intervals. The final concentration of the 
reagents were as foliows: 100 mM HEPES (pH 
7.5); 55 pM Tf; 109 pM Fe (II) or Fe(II1) in the 
form of ferrous or ferric ammonium sulfate; and 
1.88 PM Cp. Reactions (a) through (j) contained 
ambient oxygen estimated to be 216 pM at 37°C 
and ambient CO2 concentrations at 3OOpM, except 
reaction (i) which contained 42 mM HCO?, The (f) 
and (g) experiments contained 72 mM HEPES. 
* To whom correspondence should be addressed 
Ab~reviatjo~: Cp, Ceruloplasmin; h serum, human 
serum; Tf, Ape-transferrin; Fe(IIIfz-Tf, diferric 
transferrin 
In reactions (f) and (g), the 27% fresh human 
serum used contained, in addition to 675 nM Cp, 
the following concentrations: 165 ,uM albumin; 11 
,uM ascorbic acid: 7.3 mM bicarbonate; 135 FM 
phosphate; 8.1 FM (113) ferric-saturated Tf. These 
serum concentrations were estimated from stan- 
dard tables [IO]. The amount of Fe(III)z-Tf form- 
ed was calculated using CmM = 4.56; a MI of 
80000 was assumed for Tf Ill]. The pH of the 
final reaction mixtures ranged from 7.35-7.40. 
It is recognized that the complexity of these reac- 
tions did not permit a precise measure of rate con- 
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Sequence of reactions leading to the formation of diferric transferrin 
Reactants Comments 
!; 
Tf + Fe(I1) Auto-oxidation of Fe(I1). Slower than (c) or (d) 
Fe(I1) + Tf Auto-oxidation of Fe(I1); rate and saturation less than (a) 
(c) Tf + Cp + Fe(I1) Cp catalyzed; rate a (d) (in vivo sequence) 
(d) Fe(E) + Tf + Cp Auto-oxidation followed by Cp catalysis = (c) 
: 
Fe(I1) + Cp + Tf Cp catalyzed, Fe(I1) oxidation rapid; Tf saturation low 
Tf + h serum + Fe(B) Fast at 27% h serum (in vivo conditions) 
(s) Fe(E) + h serum + Tf Rate c(f) >(e) 
$) 
Tf + Fe(II1) Slowest rate due to [Fe(OH),]. 
Fe(III) + Tf Similar to (h) 
ti) Fe(II1) + Tf With 42 mM HCO? faster than (i) 
Each reactant was added at 1-min intervals. All reactions contained ambient 02 (216 yM), ambient 
HCO; (3OOpM) and HEPES buffer (pH 7.5): Fe(E), Fe(II1) = 109~M; Tf = 55 PM; Cp = 1.88 PM 
&ants. Thus our data are confined to relative rates 
of Fe(III)z-Tf formation. 
3. RESULTS 
The various reactants, their order of addition 
and Fe(III)z-Tf formation are shown in table 1 
and fig. 1 and 2. Each reagent was mixed at 1-min 
intervals (except for a 5-min interval in the reaction 
represented by curve b’, fig. 1). In fig. 1, the per- 
cent Fe(II1) saturation of Tf is shown at 1-min in- 
tervals for 30 min. Fig. 2 shows the formation of 
Fe(III)z-Tf in several reactions for an expanded 
time scale for the first 3 min. The comments in- 
cluded in table 1 compare the relative rates of these 
reactions. 
Reactants (a) (fig. 1,2) show the rates of 
Fe(III)z-Tf formation by Fe(I1) and Tf. This was 
assumed to be the rate of auto oxidation of Fe(I1) 
and was relatively slow compared to (c) which cor- 
responds to a physiological sequence. The rate of 
(a) was less than that of (d) as shown by the im- 
mediate increase in rate when 1.88 /rM Cp was add- 
ed after 1 min (arrow, fig. 2). 
Fe(I1) ions kept in buffer (pH 7.5) for 1 min and 
5 min before the addition of Tf showed con- 
siderable reduction in the rate of Tf saturation (fig. 
1, curves (b) and (b ’ )). The results indicate that Tf 
and Fe(I1) ions should be present in the reaction 
mixture to achieve maximum extent of saturation. 
Fig. 1, curve (c) shows that iron saturation after 
oxidation of Fe(I1) to Fe(II1) was instantaneous. In 
fig. 2 a lo-fold increase in the rate is seen between 
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Fig. 1. The percent of Fe(III)s-Tf formation was studied 
for 30 min at 37OC in l-ml cuvettes containing HEPES 
buffer (pH 7.5). The reagents were added at 1-min 
intervals. For procedures and sequence of additions see 
section 2 and table 1. The identification of the curves is 
given in table 1. 
Volume 159, number 1,2 FEBS LETTERS August 1983 
e 
D-D- 
t/ 
h .-.-.-.- 
0.00 
TIME (MIN.) 
Fig. 2. Absorbance at 465 nm during the formation of 
Fe(IIIkTf of an expanded time scale for the first 3 min 
of the reactions indicated in table 1. 
(a) and (c). Since Fe(I1) ions were added last, there 
is little, if any, evidence for Fe(II)-Tf interaction. 
In reaction (d), since Cp was added last, there is 
a possibility of Fe(II)-Tf interaction. Subtracting 
the auto-oxidation for the first min gave a IO-fold 
increase in the enzymic oxidation and in 
Fe(III)z-Tf formation (fig. 2, curve d). 
When Cp and Fe(I1) ions were mixed, Fe(II1) 
ions were formed instantaneously because of fer- 
roxidase activity. When Tf was added after 1 min, 
no specific saturation of Tf took place. Less than 
15% saturation was observed in the first 5 min (fig. 
1 curve (e)). 
In reaction (f), human serum diluted to 27% was 
used and 97% saturation of Tf was obtained in 1 
min. This reaction corresponds to an in vivo 
sequence. 
When serum and Fe(I1) ions were mixed (g), 
Fe(II1) ions were formed almost instantaneously 
primarily because of the ferroxidase activity of Cp 
in the serum (estimated to be 0.68 FM). When Tf 
was added after 1 min, 90% saturation was seen 
after 10 min. Thus (g) is much faster than (e) which 
had a similar sequence but no serum. 
Ferric ions showed the slowest rate of iron 
transfer to Tf (reactions (h), (i), not shown). 
However, in the presence of 42 mM HCO? (reac- 
tion (j)), Fe(II1) gave a much faster rate than reac- 
tion (e). 
4. DISCUSSION 
Our results support a role of Cp in promoting 
the saturation of Tf when the reactants were added 
in a correct physiological sequence. The fastest 
reactions shown in fig. 1 and 2 are (c), (d) after Cp 
addition, and (f). Reactions (c) and (f) occur under 
conditions similar to those expected in serum. In 
(c), Fe(I1) is added to a mixture of Tf and Cp and 
in (f) Fe(I1) confronts a mixture of Tf and 27% h 
serum. Reaction (e) is of no physiological 
significance. 
Reactions (a), (c) and (e) show a relative rate 
similar to the corresponding reactions reported in 
[6]. On the basis of reactions similar to (a), (c) and 
(e), they concluded that ‘Tf reacts with iron which 
has been oxidized to Fe(II1) by Cp’. While this 
conclusion might fit reactants in (e), it is not con- 
sistent with the high rate observed for reactants (c), 
(d) and (f). They also contended that ‘Cp seems to 
catalyse the formation of Fe(III)z-Tf when Fe(I1) 
has been complexed with Tf’. This is not in accord 
with the fact that (d) is no faster than (c) in which 
Tf is mixed with Cp before Fe(I1). 
The slower reactions (b), (b’), (e) and (h) involve 
delayed mixing of Tf with Fe(I1) or Fe(II1) ions at 
pH 7.5. These rates are due to hydrolysis [ 121 and 
polymerization of Fe(II1) or Fe(I1) which is auto- 
oxidized to Fe(II1). The rate of the auto-oxidation 
of Fe(I1) in the presence of Tf, reaction (a), is 
believed to reflect a balanced oxidation and Tf 
reaction. Thus, there is little chance for Fe(II1) to 
be hydrolysed before it is complexed by Tf. The 
fact that reaction (g) is considerably faster than (e) 
suggests that serum components, other than Cp, 
maintain Fe(I1) or Fe(II1) in a more available 
form. 
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A comparison of (j) with (h) and (i) suggests the 
formation of a Fe(III)-HCO? complex which can 
transfer Fe(II1) to Tf before extensive hydrolysis. 
High concentration of HCO: (27 mM) found in 
serum may also prevent iron polymerization to 
form a reactive Fe(III)-HCO? complex and subse- 
quently Tf saturation, in agreement with an earlier 
report from this laboratory [13]. 
The use of serum and the appropriate order of 
additions in our experiments in table 1 were of a 
more realistic design than other published studies 
of the formation of diferric-Tf from Fe(I1). 
However, because of experimental limitations we 
could not match in vivo conditions precisely. All 
experiments used dissolved oxygen at -216 pM, 
higher than found in the plasma (53-120 pM). 
However, the reduction in oxygen concentrations 
would not affect the rate of the Cp-catalyzed reac- 
tions, since Cp is saturated at low oxygen levels, 
- 1OpM [3]. In contrast, the rate of Fe(I1) oxida- 
tion is likely to be first order with respect to low 
oxygen concentrations [3]. The physiological con- 
centration of Fe(I1) is another example. When 
Fe(III)z-Tf is used as the end point, Fe(I1) must be 
2 109pM. Yet it is estimated that free Fe(I1) con- 
centration in the plasma is < 1pM 131. Again this 
would lower the rates with Fe(I1) alone by factor of 
100, but would not affect the Cp oxidation, since 
it has a Km of 0.6/1M for Fe(I1) [14]. We also note 
that the concentration of ascorbate (1 mM) used in 
[6] was 20-30-times greater than typical serum 
levels. Other constituents of serum also have been 
shown to have a marked effect on Fe(III)z-Tf for- 
mation [15]. Neither in [6] nor in [7] have these 
facts been taken into account if the design of their 
reactions was intended to represent in vivo 
conditions. 
Finally, we note that Cp offers a distinct 
qualitative advantage in Fe(I1) oxidation since it 
produces no superoxide, peroxide nor hydroxyl 
radicals [ 151. These oxygen by-products have been 
reported for the auto-oxidation of Fe(I1) [16]. 
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